122 related articles for article (PubMed ID: 10616774)
1. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
Gotoda T; Saito D; Kondo H; Ono H; Oda I; Fujishiro M; Yamaguchi H
J Gastroenterol; 1999; 34 Suppl 11():91-6. PubMed ID: 10616774
[TBL] [Abstract][Full Text] [Related]
2. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
4. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
5. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Uemura N; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Haruma K; Sumii K; Kajiyama G
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):639-42. PubMed ID: 9264278
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
Kato S; Ozawa K; Sekine H; Ohyauchi M; Shimosegawa T; Minoura T; Iinuma K
J Gastroenterol; 2005 Jan; 40(1):94-7. PubMed ID: 15692795
[TBL] [Abstract][Full Text] [Related]
9. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
[TBL] [Abstract][Full Text] [Related]
10. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Kikuchi S; Kato M; Katsuyama T; Tominaga S; Asaka M
Helicobacter; 2006 Jun; 11(3):147-51. PubMed ID: 16684261
[TBL] [Abstract][Full Text] [Related]
11. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
Maconi G; Parente F; Russo A; Vago L; Imbesi V; Bianchi Porro G
Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
[TBL] [Abstract][Full Text] [Related]
12. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
14. Dual versus triple therapy in eradication of Helicobacter pylori.
Ohlin B; Cederberg A; Kjellin T; Kullman E; Melén K; von Holstein CS; Thoring M
Hepatogastroenterology; 2002; 49(43):172-5. PubMed ID: 11941946
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Lamouliatte H; Perie F; Joubert-Collin M
Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
17. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
18. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
20. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Mohar A; Ley C; Guarner J; Herrera-Goepfert R; Figueroa LS; Halperin D; Parsonnet J
Am J Gastroenterol; 2002 Oct; 97(10):2530-5. PubMed ID: 12385434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
